title: Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat.
abstract: OBJECTIVE
  Postural hypotension is a common side-effect of L-DOPA treatment of Parkinson's disease, and may be potentiated when L-DOPA is combined with selegiline, a selective inhibitor of monoamine oxidase B (MAO-B). Rasagiline is a new, potent and selective MAO-B inhibitor, which does not possess the sympathomimetic effects of selegiline. We have studied the effects of these selective MAO inhibitors, L-DOPA and dopamine on the cardiovascular system of the rat.
  
  
  METHODS
  Blood pressure and heart rate was measured in conscious rats following acute or chronic administration of rasagiline, selegiline and L-DOPA, by comparison with the selective MAO-A inhibitor clorgyline, or the MAO-A/B inhibitor tranylcypromine. Cardiovascular responses, catecholamine release, and modification of pressor response to dopamine were studied in pithed rats.
  
  
  RESULTS
  In conscious rats neither rasagiline nor selegiline caused significant potentiation of the effects of L-DOPA (50, 100, 150 mg.kg(-1)) on blood pressure or heart rate at doses which selectively inhibited MAO-B, but L-DOPA responses were potentiated by clorgyline and tranylcypromine. In rats treated twice daily for 8 days with L-DOPA and carbidopa, selegiline (5 mg.kg(-1)) but not rasagiline (0.2 mg.kg(-1)) caused a significant hypotensive response to L-DOPA and carbidopa, although both drugs caused similar inhibition of MAO-A and MAO-B. In pithed rats, selegiline but not rasagiline increased catecholamine release and heart rate, and potentiated dopamine pressor response at MAO-B selective dose.
  
  
  CONCLUSIONS
  The different responses to the two MAO-B inhibitors may be explained by the amine releasing effect of amphetamine metabolites formed from selegiline.
authors.affiliation: Department of Pharmacology, Rappaport Family Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel. finberg@tx.technion.ac.il
authors.forename: J P M
authors.initials: JP
authors.lastname: Finberg
authors.forename: A
authors.initials: A
authors.lastname: Gross
authors.forename: O
authors.initials: O
authors.lastname: Bar-Am
authors.forename: R
authors.initials: R
authors.lastname: Friedman
authors.forename: Y
authors.initials: Y
authors.lastname: Loboda
authors.forename: M B H
authors.initials: MB
authors.lastname: Youdim
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects*; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D008995:Monoamine Oxidase / Q000187:drug effects*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D008996:Monoamine Oxidase Inhibitors; D007980:Levodopa; D008995:Monoamine Oxidase